A New Combined Model for End-Stage Liver Disease Excluding INR (CMELD-XI) Score Better Predicts Pediatric Heart Transplant Outcomes
The Model for end-stage liver disease (MELD) score, derived based on serum creatinine, bilirubin, and INR, was developed to accurately predict the probability of waitlist mortality in patients awaiting a liver transplant. Subsequently, a MELD excluding INR (MELD-XI) score was adapted to predict mortality after heart transplant (HT). Our objective was to devise a new combined scoring model (defined as CMELD-XI, derived by adding the MELD-XI score with independent predictors of 1-year mortality) to accurately predict mortality after pediatric HT (PHT).
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: S. Choudhry, K.E. Hosek, S.W. Denfield, J.F. Price, A.G. Cabrera, H.P. Tunuguntla, V.R. Dharnidharka, C.E. Canter, W.J. Dreyer Source Type: research
More News: Bilirubin | Cardiology | Heart | Heart Transplant | Liver | Liver Disease | Liver Transplant | Lung Transplant | Pediatrics | Transplant Surgery | Transplants | Urology & Nephrology